Invesco Ltd. has increased its stake in Collegium Pharmaceutical, Inc., now holding approximately 3.9% of the company's common stock. This update, detailed in a recent SEC filing, highlights the growing interest in Collegium within the pharmaceutical preparations sector.
Collegium Pharmaceutical, Inc. is a Virginia-based company specializing in pharmaceutical preparations, listed on the Nasdaq under the ticker COLL. The company has been active in the market, with several recent filings, including a 10-Q and an 8-K, both filed on November 5, 2026.
The latest filing, a Schedule 13G/A submitted on November 10, 2026, reveals that Invesco Ltd. beneficially owns 1,261,037 shares of Collegium. The filing states, "Invesco Ltd., in its capacity as a parent holding company to its investment advisers, may be deemed to beneficially own 1,261,037 shares of the Issuer which are held of record by clients of Invesco Ltd." This represents a significant investment that may influence Collegium's strategic direction.
The filing indicates that Invesco has sole voting power over 1,260,828 shares and sole dispositive power over the same number of shares, indicating a strong position in terms of decision-making. The report also notes that no single person has greater than 5% economic ownership in the securities, suggesting a diversified client base for Invesco.
This development could impact Collegium's relationships with its investors and how it approaches future business strategies. As a large accelerated filer, Collegium is under scrutiny to maintain transparency and effective communication with its shareholders, especially with a significant stakeholder like Invesco involved.
Looking ahead, the filing does not specify any immediate next steps or actions that Collegium will take in response to this change in ownership. However, the presence of a notable investment firm like Invesco may prompt Collegium to engage more actively with its investor base and consider strategies that align with shareholder interests.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





